Suppr超能文献

氨基甲酸乙酯对排尿的谷氨酸能控制的改变。

Alteration by urethane of glutamatergic control of micturition.

作者信息

Yoshiyama M, Roppolo J R, De Groat W C

机构信息

Department of Pharmacology, School of Medicine, University of Pittsburgh, PA 15261.

出版信息

Eur J Pharmacol. 1994 Nov 3;264(3):417-25. doi: 10.1016/0014-2999(94)00505-2.

Abstract

The i.v. administration of MK-801 (0.001-3 mg/kg), a non-competitive NMDA receptor antagonist, did not alter reflex bladder activity in unanesthetized decerebrate rat recorded during fast infusion (0.21 ml/min) cystometry or under isovolumetric conditions, but did depress reflex bladder contractions in doses between 0.1 and 3 mg/kg i.v. in the urethane-anesthetized (1.2 g/kg s.c.) intact rat during fast infusion cystometry. The ED50 and the dose to produce maximal inhibition in urethane-anesthetized intact rats were 0.25 mg/kg and 3 mg/kg i.v., respectively. During slow infusion (0.04 ml/min) cystometry, in unanesthetized decerebrate rats, MK-801 (0.1-1 mg/kg i.v. or 6-60 micrograms i.t.) decreased by 12-44% the micturition volume threshold (VT) but did not change the amplitude and duration of the bladder contractions. The administration of a larger i.t. dose (60 micrograms) of MK-801 produced no further decrease in VT but decreased the amplitude of bladder contractions by 24%. External urethral sphincter electromyogram activity was reduced or abolished by MK-801 (0.01-3 mg/kg i.v.) in both unanesthetized decerebrate and urethane-anesthetized intact rats with ED50 of 0.12 mg/kg and 0.05 mg/kg, respectively. These results indicate that NMDA receptors play an important role in both facilitatory and inhibitory central neural control of voiding function and that there is a significant interaction between urethane anesthesia and NMDA glutamatergic transmission. Thus, even though urethane anesthesia has been useful for studying the physiological characteristics of the micturition reflex, it seems inappropriate for analyzing the normal transmitter role of glutamic acid in reflex voiding.

摘要

非竞争性N-甲基-D-天冬氨酸(NMDA)受体拮抗剂MK-801静脉注射(0.001 - 3毫克/千克),在快速灌注(0.21毫升/分钟)膀胱测压期间或等容条件下记录的未麻醉去大脑大鼠中,并未改变反射性膀胱活动,但在氨基甲酸乙酯麻醉(1.2克/千克皮下注射)的完整大鼠快速灌注膀胱测压期间,静脉注射剂量在0.1至3毫克/千克时,确实会抑制反射性膀胱收缩。在氨基甲酸乙酯麻醉的完整大鼠中,产生最大抑制作用的半数有效剂量(ED50)和剂量分别为静脉注射0.25毫克/千克和毫克/千克。在未麻醉去大脑大鼠的缓慢灌注(0.04毫升/分钟)膀胱测压期间,MK-801(静脉注射0.1 - 1毫克/千克或鞘内注射6 - 60微克)使排尿量阈值(VT)降低了12 - 44%,但并未改变膀胱收缩的幅度和持续时间。鞘内注射更大剂量(60微克)的MK-801并没有使VT进一步降低,但使膀胱收缩幅度降低了24%。在未麻醉去大脑和氨基甲酸乙酯麻醉的完整大鼠中,MK-801(静脉注射0.01 - 3毫克/千克)均可降低或消除尿道外括约肌肌电图活动,其ED50分别为0.12毫克/千克和0.05毫克/千克。这些结果表明,NMDA受体在排尿功能的促进性和抑制性中枢神经控制中均起重要作用,并且氨基甲酸乙酯麻醉与NMDA谷氨酸能传递之间存在显著相互作用。因此,尽管氨基甲酸乙酯麻醉对于研究排尿反射的生理特征很有用,但似乎不适用于分析谷氨酸在反射性排尿中的正常递质作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验